H. Wurziger
Papers
1
Total Citations
3
H-Index
1
About
H. Wurziger is a pioneer in the integration of miniaturized synthesis and biological screening, a field critical to accelerating early-stage drug discovery. Their most-cited work, a 2013 study on a "robotic alliance" for identifying histone deacetylase inhibitors, tackles a major bottleneck in preclinical pharmaceutics: the separation of compound synthesis from screening, which typically requires complex and loss-prone compound storage. By demonstrating a fully automated, miniaturized workflow that unites these processes, Wurziger’s research directly addresses the inefficiencies of traditional drug development pipelines. This contribution, while niche, has garnered 3 citations and serves as a foundational case study for labs seeking to implement high-throughput, integrated platforms. Wurziger’s work is particularly notable for its focus on practical, robotic solutions that reduce material waste and accelerate hit identification, making it a valuable reference for researchers in medicinal chemistry and automated synthesis. Their approach exemplifies how engineering and chemistry converge to streamline the path from molecule to therapeutic candidate.
Research Focus
Key Achievements
Top Papers
- 1